Brevan Howard Capital Management’s Labcorp LH Stock Holding History

Brevan Howard Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	+8,660	New	+$2.28M	0.02%	638
2025 Q4	–	Sell	-1,200	Closed	-$344K	–	2073
2025 Q3	$344K	Sell	1,200 -276	-19%	-$73.9K	﹤0.01%	1493
2025 Q2	$387K	Sell	1,476 -214	-13%	-$52.1K	﹤0.01%	1459
2025 Q1	$393K	Buy	+1,690	New	+$410K	﹤0.01%	784
2024 Q4	–	Sell	-1,374	Closed	-$307K	–	1264
2024 Q3	$307K	Sell	1,374 -457	-25%	-$100K	﹤0.01%	848
2024 Q2	$373K	Buy	+1,831	New	+$372K	﹤0.01%	708
2024 Q1	–	Sell	-2,441	Closed	-$555K	–	1188
2023 Q4	$555K	Buy	+2,441	New	+$513K	0.01%	436

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brevan Howard Capital Management's LH Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Labcorp (LH) in Q2 2026: 8,660 shares worth $2.42M. The stake represents 0.02% of the portfolio and ranks #638 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in LH as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in LH in Q4 2023 and has held it in 7 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Brevan Howard Capital Management held 8,660 shares of Labcorp worth $2.42M as of Q2 2026.
Labcorp was a new Brevan Howard Capital Management position in Q2 2026.
Labcorp made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #638 holding.
Brevan Howard Capital Management first reported a position in Labcorp in Q4 2023 and has held it in 7 quarters since.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.